Atezolizumab Fails to Improve PFS in Advanced Squamous Cell Penile Cancer

The phase 2 PERICLES trial of atezolizumab with or without radiotherapy in patients with stage IV cancer did not meet its primary end point of 1-year progression-free survival.

Immunotherapy with or without radiotherapy did not demonstrate efficacy in patients with advanced squamous cell carcinoma of the penis, according to data presented by Hielke Martijn de Vries, MD, of Netherlands Cancer…

Continue Reading

News Source:

Leave a comment

Your email address will not be published.